BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors
BRCA2 plays important roles in cell physiology by promoting DNA replication and DNA double-strand breaks repair. Here the authors, reveal the impact of BRCA2 depletion on the cell transcriptional program with activation of the innate immune response that is potentiated by PARP inhibitor treatments.
Guardado en:
Autores principales: | Timo Reisländer, Emilia Puig Lombardi, Florian J. Groelly, Ana Miar, Manuela Porru, Serena Di Vito, Benjamin Wright, Helen Lockstone, Annamaria Biroccio, Adrian Harris, Arturo Londoño-Vallejo, Madalena Tarsounas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a4c12a795f2a4463a4d0d639093cc868 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A transcription-based mechanism for oncogenic β-catenin-induced lethality in BRCA1/2-deficient cells
por: Rebecca A. Dagg, et al.
Publicado: (2021) -
Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies
por: Xia Ding, et al.
Publicado: (2016) -
Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition
por: Diar Aziz, et al.
Publicado: (2021) -
BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance
por: Yifan Wang, et al.
Publicado: (2019) -
Hypersensitivity of BRCA2 deficient cells to rosemary extract explained by weak PARP inhibitory activity
por: Cathy Su, et al.
Publicado: (2017)